Acadia Pharmaceuticals (ACAD) Stock Target Lowered to $33
Published on Β· Source: investing.com
AI Summary
Summarized by AI from the source belowH.C. Wainwright has lowered the price target for Acadia Pharmaceuticals (ACAD) to $33. This adjustment reflects changes in market expectations and financial analysis, indicating a revision from previous forecasts. A lower price target can influence investor sentiment and trading behavior. The change may affect how investors approach Acadia's stock moving forward.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Understand this kind of story
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
